Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis

Study Type – Therapy (case series)

[1]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[2]  B. Bochner,et al.  The effect of age and gender on bladder cancer: a critical review of the literature , 2010, BJU international.

[3]  E. Messing,et al.  Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? , 2009, Urology.

[4]  Cheryl T. Lee,et al.  Patterns of hematuria referral to urologists: does a gender disparity exist? , 2008, Urology.

[5]  J. Wright,et al.  The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy , 2008, Cancer.

[6]  M. Nørgaard,et al.  Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study. , 2008, Urology.

[7]  B. Czerniak,et al.  Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder , 2007, Cancer.

[8]  M. Srougi,et al.  The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy. , 2007, International braz j urol : official journal of the Brazilian Society of Urology.

[9]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[10]  A. Hemal,et al.  1319: Comparison of Three Analgesic Protocols for Pain Control During Shock Wave Lithotripsy using Dornier Alpha Compact Lithotripter: A Prospective Randomized Clinical Trial , 2007 .

[11]  D. Bajorin,et al.  Defining optimal therapy for muscle invasive bladder cancer. , 2007, The Journal of urology.

[12]  B. Konety,et al.  Complications after radical cystectomy: analysis of population-based data. , 2006, Urology.

[13]  Y. Lotan,et al.  Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[14]  D. Michaud,et al.  Hormonal and reproductive factors and the risk of bladder cancer in women. , 2006, American journal of epidemiology.

[15]  John T. Wei,et al.  Racial disparities in resource utilization for cystectomy. , 2006, Urology.

[16]  S. Boorjian,et al.  Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. , 2004, Urology.

[17]  F. Burkhard,et al.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Walsh.  Determining Cause of Death in Prostate Cancer: Are Death Certificates Valid? , 2002 .

[19]  P. Nelson,et al.  Determining cause of death in prostate cancer: are death certificates valid? , 2001, Journal of the National Cancer Institute.

[20]  Theresa M. Wizemann,et al.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[21]  P. Russo,et al.  Cystectomy for bladder cancer: a contemporary series. , 2001, The Journal of urology.

[22]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Gustafsson,et al.  Erratum: Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract (Molecular and Cellular Endocrinology 164 (2000) (109-116) PII: S0303720700002331) , 2000 .

[24]  J. Gustafsson,et al.  Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract , 2000, Molecular and Cellular Endocrinology.

[25]  V. Serretta,et al.  Pure Squamous Cell Carcinoma of the Bladder in Western Countries , 2000, European Urology.

[26]  J. Hanley,et al.  Statistical considerations when assessing outcomes following treatment for prostate cancer. , 1999, Journal of Urology.

[27]  Pierre I Karakiewicz,et al.  A population‐based competing‐risks analysis of the survival of patients treated with radical cystectomy for bladder cancer , 2011, Cancer.

[28]  R. Millikan,et al.  Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. , 2007, Urology.

[29]  V. Muller.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[30]  J. Gustafsson,et al.  Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. , 2000, Molecular and cellular endocrinology.

[31]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[32]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .